Follow us
  • Prof. Dr. Sergi Trilla, MBA Prof. Dr. Sergi Trilla, MBA
  • Ricardo Acin Ricardo Acin
  • Joan Ribera Joan Ribera
  • Dra. Marta Fernández Dra. Marta Fernández
  • Christopher Jensen, M.D. Christopher Jensen, M.D.
  • Alvar Bertolin Alvar Bertolin
  • Albert Figueras Albert Figueras
  • Roy Bateman, MBA Roy Bateman, MBA
  • Sonia Sanhueza, PhD Sonia Sanhueza, PhD
  • Neil Mellor Neil Mellor
  • Julia Berges, PhD, MBA Julia Berges, PhD, MBA
  • Mario Schäfer Mario Schäfer
  • Cora Griffin, PhD Cora Griffin, PhD
  • Clara Nascimento, PhD Clara Nascimento, PhD
  • Diana Vanegas Diana Vanegas
  • Carla Giménez Carla Giménez
  • Naiara Valtierra Naiara Valtierra
  • Laia Ramoneda Laia Ramoneda
  • Nina Canyes Nina Canyes
  • Claudia Gómez Claudia Gómez
  • Tomasz Barałkiewicz Tomasz Barałkiewicz
  • Tetsuya Takada, R.Ph, MBA Tetsuya Takada, R.Ph, MBA
  • "Pharmacelera is a software company for Computer-Aided Drug Design. We were put in contact with Trifermed through a start-up acceleration program and people from their team acted as our business model mentors. Through the professional guidance of Trifermed, we have been able to improve our value proposition and to establish links with relevant stakeholders from the pharma industry. We are very grateful for Trifermed's help and we will definitely continue strenghtening our relationship with them."

    Enric Gibert, CEO, Pharmacelera, Spain
  • "We have been working with Trifermed for more than 6 years now, and our relationship has been most pleasant and fruitful. Prevtec Microbia is a biotech company in animal health and our 5-year business plan then called for launching 3 products, in 12 countries over 4 continents. Today, Prevtec has a global presence and Trifermed was instrumental in our international business development, helping us to sign distribution agreements with large pharmaceutical companies in various parts of the world.”

    Michel Fortin, President CEO, Prevtec Microbia, Canada
  • "Cipher was seeking to expand the market for our tramadol product into Latin America and engaged Trifermed for assistance based on the recommendation from a former client. The combination of Trifermed's business network, local market knowledge and project management expertise was instrumental in the successful licensing of our product to one to the top pharmaceutical companies in the region. The Trifermed team proved to be very responsive, persistent and eager to help us achieve our goal."

    Peter Weiler, Senior Director, Portfolio Development, Cipher Pharmaceuticals Inc., Canada

Latest Testimonials

→ View Full Testimonial List